322 related articles for article (PubMed ID: 20331580)
1. Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
Layer P; Andresen V
Aliment Pharmacol Ther; 2010 Jun; 31(11):1155-64. PubMed ID: 20331580
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.
Ericsson CD
Drug Saf; 2006; 29(3):201-7. PubMed ID: 16524320
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea.
Ng QX; Ho CYX; Shin D; Venkatanarayanan N; Chan HW
J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498921
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: the epidemiology and clinical features of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2009 Aug; 30(3):187-96. PubMed ID: 19392866
[TBL] [Abstract][Full Text] [Related]
6. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
DuPont HL
Drugs; 2006; 66(3):303-14. PubMed ID: 16526819
[TBL] [Abstract][Full Text] [Related]
7. Travellers' diarrhoea.
Ericsson CD
Int J Antimicrob Agents; 2003 Feb; 21(2):116-24. PubMed ID: 12615374
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers' diarrhoea.
Lääveri T; Sterne J; Rombo L; Kantele A
Travel Med Infect Dis; 2016; 14(4):299-312. PubMed ID: 27363327
[TBL] [Abstract][Full Text] [Related]
9. Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo.
Silberschmidt G; Schick MT; Steffen R; Kilpatrick ME; Murphy JR; Oyofo BA; el-Etr S; Gyurech D; Mourad AS; Mathewson JT
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):871-5. PubMed ID: 8574720
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic treatment of travellers' diarrhea].
Klinge L; de Muckadell OB
Ugeskr Laeger; 2001 Aug; 163(34):4571-3. PubMed ID: 11530563
[TBL] [Abstract][Full Text] [Related]
11. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27503854
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: prevention of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2008 May; 27(9):741-51. PubMed ID: 18284650
[TBL] [Abstract][Full Text] [Related]
13. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
Dupont HL; Jiang ZD; Belkind-Gerson J; Okhuysen PC; Ericsson CD; Ke S; Huang DB; Dupont MW; Adachi JA; De La Cabada FJ; Taylor DN; Jaini S; Martinez Sandoval F
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):451-6. PubMed ID: 17382603
[TBL] [Abstract][Full Text] [Related]
14. ▾Rifaximin for the treatment of travellers' diarrhoea?
Drug Ther Bull; 2013 Jan; 51(1):10-2. PubMed ID: 23303506
[TBL] [Abstract][Full Text] [Related]
15. Review article: prevention and treatment of travellers' diarrhoea.
Farthing MJ
Aliment Pharmacol Ther; 1991 Feb; 5(1):15-30. PubMed ID: 1932478
[TBL] [Abstract][Full Text] [Related]
16. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2017 Apr; 24(suppl_1):S57-S62. PubMed ID: 28881862
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
[TBL] [Abstract][Full Text] [Related]
18. Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.
Steffen R; Jiang ZD; Gracias Garcia ML; Araujo P; Stiess M; Nacak T; Greinwald R; DuPont HL
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30462260
[TBL] [Abstract][Full Text] [Related]
19. Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea.
Wiström J; Gentry LO; Palmgren AC; Price M; Nord CE; Ljungh A; Norrby SR
J Antimicrob Chemother; 1992 Nov; 30(5):693-706. PubMed ID: 1493985
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin: a review of its use in the management of traveller's diarrhoea.
Robins GW; Wellington K
Drugs; 2005; 65(12):1697-713. PubMed ID: 16060706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
